Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Process for preparing higher hydridosilanes
Shape memory polymers formed by self-crosslinking of copolymers
Bend resistant cable
Probe for ultrasound diagnostic apparatus
Low power voltage controlled oscillator (VCO)
Key management policies for cryptographic keys
Far field telemetry operations between an external device and an implantable medical device during recharge of the implantable medical device via a proximity coupling
  Randomly Featured Patents
Process for preparing phosphated or nitrophosphated fertilizers through solubilization of phosphate rock
Torque motor having uniform torque output characteristic
Circuit and method for computing a fast fourier transform
Fire resistant structural material, fabrics made therefrom
Object detection device
Face panel for a HPCI board
Panels for overhead folding door and their articulating connections
System for interconnecting parking meters having a memory
Assembly for infeed table
Laundering aid